EMA
label_change
· 2017-06-23
EMA recommends that Symbioflor 2 can continue to be used for irritable bowel syndrome
Summary
EMA recommends that Symbioflor 2 can continue to be used for irritable bowel syndrome, indicating ongoing authorization status and review outcome.
Upgrade for the full analysis, importance score, and drug timeline.